Evidence map›Paper›PMID 40724934›Full record

ArticleInternational journal of molecular sciences2025

Polyclonal LC3B Antibodies Generate Non-Specific Staining in the Nucleus of Herpes Simplex Virus Type 1-Infected Cells: Caution in the Interpretation of LC3 Staining in the Immunofluorescence Analysis of Viral Infections.

Inés Ripa, Sabina Andreu, Daniel Galdo, Oliver Caballero, Raquel Bello-Morales, José Antonio López-Guerrero

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Inés RipaDepartment of Molecular Biology, Universidad Autónoma de Madrid, 28049 Madrid, Spain.ORCID 0000-0001-7007-5401
Sabina AndreuDepartment of Molecular Biology, Universidad Autónoma de Madrid, 28049 Madrid, Spain.ORCID 0000-0003-0600-4152
Daniel GaldoDepartment of Molecular Biology, Universidad Autónoma de Madrid, 28049 Madrid, Spain.ORCID 0009-0006-3532-4760
Oliver CaballeroDepartment of Molecular Biology, Universidad Autónoma de Madrid, 28049 Madrid, Spain.ORCID 0009-0003-9129-6600
Raquel Bello-MoralesDepartment of Molecular Biology, Universidad Autónoma de Madrid, 28049 Madrid, Spain.ORCID 0000-0002-4415-6483
José Antonio López-GuerreroDepartment of Molecular Biology, Universidad Autónoma de Madrid, 28049 Madrid, Spain.ORCID 0000-0003-2817-5956

Funding

Ministerio de Ciencia e Innovación PID2022-140632NB-I00
6 · The paper itself

Abstract

The most common marker used to monitor autophagy is the microtubule-associated protein light chain 3 (LC3). Upon induction of autophagy, LC3 is conjugated to phosphatidylethanolamine and targeted to autophagic membranes, which can be easily detected by immunofluorescence. However, this technique has some limitations. During the early stages of HSV-1 infection, strong LC3B nuclear staining is observed within the viral replication compartments. This staining is only detected when using polyclonal antibodies. It is noteworthy that monoclonal antibodies or the GFP-LC3 plasmid do not reveal any nuclear LC3 staining. Interestingly, LC3B is not detected in the nuclear fraction of infected cells by Western blotting, even when polyclonal antibodies are used. In infected LC3B knockout cells, nuclear staining is still observed when using polyclonal LC3B antibodies. This suggests that polyclonal LC3B antibodies generate non-specific nuclear staining in infected cells, which could result in misinterpretation and erroneous conclusions. These findings raise questions about the reliability of LC3-immunofluorescence assays in herpesvirus infections. It is imperative that the methodology employed for monitoring autophagy by immunofluorescence in viral infections be reviewed and updated, and that the specificity of anti-LC3B antibodies be tested before use. To ensure the accuracy of the results, it is essential to validate this technique with additional assays, such as by immunoblot analysis or via the use of autophagy-deficient cell lines.

Indexed as

AntibodiesCell NucleusFluorescent Antibody TechniqueHerpes SimplexHerpesvirus 1, HumanMicrotubule-Associated ProteinsAnimalsAutophagyChlorocebus aethiopsHumansStaining and LabelingAntibodiesMAP1LC3B protein, humanMicrotubule-Associated Proteinsautophagyherpes simplex virus type 1LC3 antibodyoligodendrocytereplication compartment

Identifiers

PMID40724934
PMCPMC12294389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.